Clinical Trial Update: A Research Study for Patients With Metastatic Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in metastatic renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasm Metastasis
• Renal Cell Carcinoma

Snippet

Sponsor: Celgene | Conditions: Carcinoma, Renal Cell, Neoplasm Metastasis | Phase 2 | Status: COMPLETED